内部人交易记录
其他基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Halladay Benjamin. Officer active across 1 company, notably Esperion Therapeutics, Inc.. In total, 17 reports have been recorded. Split: 0 buy · 11 sells. Total volume traded: €74k. History available since 9 December 2022. The latest transaction was disclosed on 17 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Halladay Benjamin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
705,410 股Common StockSEC:0001628280-26-048000:0
10,773 股Common StockSEC:0001628280-26-044264:0
6,424 股@ US$2.70543.5% 占其流量Common StockSEC:0001628280-26-019409:0
247,430 股0Common StockSEC:0001628280-26-018186:0
7,337 股@ US$3.66730.8% 占其流量Common StockSEC:0001628280-25-057942:0
7,046 股@ US$2.80832.5% 占其流量Common StockSEC:0001953943-25-000004:0
11 股@ US$1.1150.1% 占其流量Common StockSEC:0001628280-25-035334:0
7,229 股@ US$1.15237.0% 占其流量Common StockSEC:0001628280-25-032217:0
8 股@ US$0.9640.1% 占其流量Common StockSEC:0001628280-25-018566:0
3,535 股@ US$1.48339.0% 占其流量Common StockSEC:0001628280-25-013812:0
238,000 股0Common StockSEC:0001628280-25-013198:0
11 股@ US$1.860.2% 占其流量Common StockSEC:0001628280-25-006801:0
9 股@ US$2.2650.2% 占其流量Common StockSEC:0001628280-25-002037:0
3,245 股@ US$2.42460.7% 占其流量Common StockSEC:0001628280-24-051875:0
170,000 股0Common StockSEC:0001628280-24-011488:0
9,200 股0Common StockSEC:0001628280-23-007968:0
44,000 股0Common StockSEC:0001104659-22-126269:0
About Halladay Benjamin
Halladay Benjamin is Chief Financial Officer at Esperion Therapeutics, Inc. (XNAS). He has filed 10 disclosures in total, and in the recent sampled filings the activity consists entirely of sales, with sum_sell_eur at 12326 between 2022-12-12 and 2026-06-18.